M&T Bank Corp Bio Rad Laboratories, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 1,979 shares of BIO stock, worth $675,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,979

Previous 38,772 94.9%

Holding current value

$675,848

Previous $13 Million 94.9%

% of portfolio

0.0%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	SELL	$263.97 - $344.64 $9.71 Million - $12.7 Million	-36,793 Reduced 94.9%	1,979 $662,000
Q3 2024 Nov 15, 2024	BUY	$263.97 - $344.64 $9.66 Million - $12.6 Million	36,587 Added 1674.46%	38,772 $13 Million
Q2 2024 Jul 31, 2024	SELL	$268.26 - $339.48 $24,948 - $31,571	-93 Reduced 4.08%	2,185 $596,000
Q1 2024 May 07, 2024	SELL	$304.11 - $351.99 $27,978 - $32,383	-92 Reduced 3.88%	2,278 $787,000
Q4 2023 Feb 06, 2024	SELL	$269.37 - $365.04 $33,401 - $45,264	-124 Reduced 4.97%	2,370 $765,000
Q3 2023 Nov 02, 2023	SELL	$350.25 - $422.63 $132,394 - $159,754	-378 Reduced 13.16%	2,494 $893,000
Q2 2023 Aug 09, 2023	SELL	$359.49 - $486.4 $56,439 - $76,364	-157 Reduced 5.18%	2,872 $1.09 Million
Q1 2023 May 11, 2023	BUY	$418.69 - $503.0 $98,810 - $118,708	236 Added 8.45%	3,029 $1.45 Million
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $569,066 - $737,824	-1,618 Reduced 36.68%	2,793 $1.17 Million
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $524,751 - $680,366	1,492 Added 51.11%	4,411 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $226,099 - $308,666	-548 Reduced 15.81%	2,919 $1.22 Million
Q2 2022 Aug 05, 2022	BUY	$463.67 - $597.16 $850,834 - $1.1 Million	1,835 Added 112.44%	3,467 $836,000
Q1 2022 May 09, 2022	BUY	$524.57 - $735.42 $41,965 - $58,833	80 Added 5.15%	1,632 $919,000
Q4 2021 Feb 07, 2022	BUY	$708.84 - $794.68 $46,074 - $51,654	65 Added 4.37%	1,552 $1.17 Million
Q3 2021 Oct 28, 2021	BUY	$657.71 - $825.77 $5,261 - $6,606	8 Added 0.54%	1,487 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $576 - $649	1 Added 0.07%	1,479 $953,000
Q1 2021 May 06, 2021	SELL	$547.01 - $662.35 $210,051 - $254,342	-384 Reduced 20.62%	1,478 $844,000
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $462,676 - $582,965	906 Added 94.77%	1,862 $1.09 Million
Q3 2020 Nov 06, 2020	BUY	$454.43 - $535.6 $40,444 - $47,668	89 Added 10.27%	956 $493,000
Q2 2020 Jul 29, 2020	SELL	$334.87 - $493.06 $130,599 - $192,293	-390 Reduced 31.03%	867 $391,000
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $8,320 - $10,635	26 Added 2.11%	1,257 $441,000
Q4 2019 Feb 07, 2020	SELL	$319.73 - $374.2 $7,673 - $8,980	-24 Reduced 1.91%	1,231 $455,000
Q3 2019 Nov 12, 2019	SELL	$304.55 - $345.24 $52,382 - $59,381	-172 Reduced 12.05%	1,255 $419,000
Q2 2019 Aug 12, 2019	SELL	$286.93 - $312.59 $105,590 - $115,033	-368 Reduced 20.5%	1,427 $447,000
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $8,523 - $12,061	38 Added 2.16%	1,795 $549,000
Q4 2018 Feb 01, 2019	SELL	$220.1 - $309.0 $271,383 - $380,997	-1,233 Reduced 41.24%	1,757 $408,000
Q3 2018 Nov 09, 2018	BUY	$289.28 - $326.15 $6,942 - $7,827	24 Added 0.81%	2,990 $937,000
Q2 2018 Aug 10, 2018	BUY	$244.1 - $303.88 $292,187 - $363,744	1,197 Added 67.67%	2,966 $855,000
Q1 2018 May 04, 2018	SELL	$233.97 - $274.11 $99,437 - $116,496	-425 Reduced 19.37%	1,769 $443,000
Q4 2017 Feb 06, 2018	SELL	$216.94 - $271.3 $55,536 - $69,452	-256 Reduced 10.45%	2,194 $522,000
Q3 2017 Nov 13, 2017	BUY	$212.27 - $242.28 $26,746 - $30,527	126 Added 5.42%	2,450 $544,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,324	2,324 $525,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account